Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2012; 2(2):156-178. doi:10.7150/thno.4068 This issue Cite

Review

Protease-Activated Drug Development

Ki Young Choi1,3, Magdalena Swierczewska1,2,3, Seulki Lee1✉, Xiaoyuan Chen1✉

1. Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, Maryland, 20892, USA
2. Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794, USA
3. These authors are contributed equally.

✉ Corresponding author: E-mail: Shawn.Chengov and Seulki.Leegov

Citation:
Choi KY, Swierczewska M, Lee S, Chen X. Protease-Activated Drug Development. Theranostics 2012; 2(2):156-178. doi:10.7150/thno.4068. https://www.thno.org/v02p0156.htm
Other styles

File import instruction

Abstract

In this extensive review, we elucidate the importance of proteases and their role in drug development in various diseases with an emphasis on cancer. First, key proteases are introduced along with their function in disease progression. Next, we link these proteases as targets for the development of prodrugs and provide clinical examples of protease-activatable prodrugs. Finally, we provide significant design considerations needed for the development of the next generation protease-targeted and protease-activatable prodrugs.

Keywords: Protease, activatable probe, Alzheimer's disease, cancer, caspase, cathepsin, kallikrein, MMP, PSA, serine protease, aspartyl protease

Citation styles

APA
Choi, K.Y., Swierczewska, M., Lee, S., Chen, X. (2012). Protease-Activated Drug Development. Theranostics, 2(2), 156-178. https://doi.org/10.7150/thno.4068.

ACS
Choi, K.Y.; Swierczewska, M.; Lee, S.; Chen, X. Protease-Activated Drug Development. Theranostics 2012, 2 (2), 156-178. DOI: 10.7150/thno.4068.

NLM
Choi KY, Swierczewska M, Lee S, Chen X. Protease-Activated Drug Development. Theranostics 2012; 2(2):156-178. doi:10.7150/thno.4068. https://www.thno.org/v02p0156.htm

CSE
Choi KY, Swierczewska M, Lee S, Chen X. 2012. Protease-Activated Drug Development. Theranostics. 2(2):156-178.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use